OPIANT PHARMACEUTICALS, INC. reports

Company location: Santa Monica, CA
Fiscal year end: 31 December

OPIANT PHARMACEUTICALS, INC. has filed 578 SEC EDGAR filings since 11 Jan 2007

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 126-150 of 545 matching filings.

Per page

25

Current page

6

4

FORM 4

Filing date: 15 Sep 2021
Reporting date: 13 Sep 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 14 Sep 2021
Reporting date: 14 Sep 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 13 Sep 2021
Reporting date: 10 Sep 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 09 Sep 2021
Reporting date: 07 Sep 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 01 Sep 2021
Reporting date: 31 Aug 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 25 Aug 2021
Reporting date: 23 Aug 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

EFFECT File 333-258813

EFFECT filing

Filing date: 23 Aug 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 20 Aug 2021
Reporting date: 19 Aug 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

CORRESP

CORRESP filing

Filing date: 19 Aug 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

UPLOAD

UPLOAD filing

Filing date: 18 Aug 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 16 Aug 2021
Reporting date: 16 Aug 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

S-3 File 333-258813

S-3

Filing date: 13 Aug 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-38193

10-Q

Filing date: 05 Aug 2021
Reporting date: 30 Jun 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38193

8-K

Filing date: 05 Aug 2021
Reporting date: 05 Aug 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 20 Jul 2021
Reporting date: 19 Jul 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3

Filing date: 20 Jul 2021
Reporting date: 19 Jul 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38193

8-K

Filing date: 12 Jul 2021
Reporting date: 08 Jul 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38193

8-K

Filing date: 06 Jul 2021
Reporting date: 06 Jul 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 16 Jun 2021
Reporting date: 15 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 16 Jun 2021
Reporting date: 15 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 16 Jun 2021
Reporting date: 15 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 16 Jun 2021
Reporting date: 15 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 16 Jun 2021
Reporting date: 15 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 16 Jun 2021
Reporting date: 15 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38193

8-K

Filing date: 15 Jun 2021
Reporting date: 15 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .